India’s Largest Drugmaker Sun Pharma To buy US firm Organon in $11.75 billion deal; Shares Jump 7%
The New Jersey-based company Organon’s portfolio includes more than 70 products across Women’s Health and General Medicines commercialised across 140 countries, with the US, Europe, China, Canada, ...
Source: The Sunday Guardian
The New Jersey-based company Organon’s portfolio includes more than 70 products across Women’s Health and General Medicines commercialised across 140 countries, with the US, Europe, China, Canada, and Brazil among its largest markets.
